{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:12Z","timestamp":1793059992314,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1146-y","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T16:23:32Z","timestamp":1445963012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Detlev","family":"Schultze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Dollenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Alexandre","family":"Krayenb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"issue":"3","key":"1146_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2007.12.008","volume":"48","author":"RH Purcell","year":"2008","unstructured":"Purcell RH, Emerson SU. Hepatitis E: An emerging awareness of an old disease. J Hepatol. 2008;48(3):494\u2013503.","journal-title":"J Hepatol"},{"key":"1146_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcv.2013.11.013","volume":"59","author":"JE Arends","year":"2014","unstructured":"Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AIM, et al. Hepatitis E - An emerging infection in high income countries. J Clin Virol. 2014;59:81\u20138.","journal-title":"J Clin Virol"},{"key":"1146_CR3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000357098","volume":"41","author":"J Dreier","year":"2014","unstructured":"Dreier J, Juhl D. Autochthonous Hepatitis E Virus Infections: A New Transfusion- Associated Risk? Transfus Med Hemother. 2014;41:29\u201339.","journal-title":"Transfus Med Hemother"},{"key":"1146_CR4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","volume":"8","author":"HR Dalton","year":"2008","unstructured":"Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8:698\u2013709.","journal-title":"Lancet Infect Dis"},{"key":"1146_CR5","unstructured":"Federal Public Health Office, Berne, Switzerland; Meldung Infektionskrankheiten: http:\/\/www.bag.admin.ch\/k_m_meldesystem\/00733\/00804\/index.html?lang=de ; accessed June 3ed, 2015."},{"key":"1146_CR6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","volume":"109","author":"NP Chalasani","year":"2014","unstructured":"Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, et al. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol. 2014;109:950\u201366.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1146_CR7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jmv.1078","volume":"64","author":"C Berger","year":"2001","unstructured":"Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol. 2001;64(4):505\u201312.","journal-title":"J Med Virol"},{"key":"1146_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","volume":"131","author":"N Jothikumar","year":"2006","unstructured":"Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006;131:65\u201371.","journal-title":"J Virol Methods"},{"key":"1146_CR9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/lt.21958","volume":"16","author":"S Pischke","year":"2010","unstructured":"Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 2010;16:74\u201382.","journal-title":"Liver Transpl"},{"key":"1146_CR10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcv.2013.10.003","volume":"58","author":"F Abravanel","year":"2013","unstructured":"Abravanel F, Chapuy-Regaud S, Lhomme S, Miedoug\u00e9 M, Peron JM, Alric L, et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol. 2013;58:624\u20138.","journal-title":"J Clin Virol"},{"key":"1146_CR11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcv.2009.05.022","volume":"45","author":"M Fogeda","year":"2009","unstructured":"Fogeda M, de Ory F, Avellon A, Echevarria JM. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol. 2009;45:259\u201361.","journal-title":"J Clin Virol"},{"key":"1146_CR12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmv.23827","volume":"86","author":"C Hyams","year":"2014","unstructured":"Hyams C, Mabayoje DA, Copping R, Maranao D, Patel M, Labbett W, et al. Serological Cross Reactivity to CMV and EBV causes problems in the Diagnosis of Acute Hepatitis E Virus Infection. J Med Virol. 2014;86:478\u201383.","journal-title":"J Med Virol"},{"key":"1146_CR13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/rheumatology\/kep101","volume":"48","author":"A McLean-Tooke","year":"2009","unstructured":"McLean-Tooke A, Aldridge C, Waugh S, Spickett GP, Kay L. Methotrexate, rheumatoid arthritis and infection risk - what is the evidence? Rheumatology. 2009;48:867\u201371.","journal-title":"Rheumatology"},{"key":"1146_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000000675","volume":"94","author":"H Bauer","year":"2015","unstructured":"Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, et al. Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants \u2013 A French Retrospective Multicenter Study. Medicine. 2015;94:1\u20136.","journal-title":"Medicine"},{"issue":"22","key":"1146_CR15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","volume":"96","author":"WH Feng","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, et al. Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated Lymphomas. J Natl Cancer Inst. 2004;96(22):1691\u2013702.","journal-title":"J Natl Cancer Inst"},{"key":"1146_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","volume":"18","author":"H Kimura","year":"2008","unstructured":"Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein\u2013Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 2008;18:305\u201319.","journal-title":"Rev Med Virol"},{"issue":"5","key":"1146_CR17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.22783","volume":"57","author":"N Balandraud","year":"2007","unstructured":"Balandraud N, Guis S, Meynard JP, Auger I, Roudier J, Roudier C. Long-Term Treatment With Methotrexate or Tumor Necrosis Factor alpha Inhibitors Does Not Increase Epstein-Barr Virus Load in Patients With Rheumatoid Arthritis. Arthritis & Rheumatism. 2007;57(5):762\u20137.","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"1146_CR18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/CVI.00104-14","volume":"21","author":"I Corrales","year":"2014","unstructured":"Corrales I, Gim\u00e9nez E, Navarro D. Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoassays for Detection of EBV Antibodies and Categorization of EBV Infection Status Using Immunofluorescence Assays as the Reference Method. Clin Vaccine Immunol. 2014;21(5):684\u20138.","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"1146_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jcv.2007.01.006","volume":"38","author":"TW Nystad","year":"2007","unstructured":"Nystad TW, Myrmel H. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. J Clin Virol. 2007;38(4):292\u20137.","journal-title":"J Clin Virol"},{"key":"1146_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/595893","volume":"48","author":"JM Mansuy","year":"2009","unstructured":"Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis. 2009;48:373\u20134.","journal-title":"Clin Infect Dis"},{"key":"1146_CR21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/zph.12103","volume":"61","author":"C Burri","year":"2014","unstructured":"Burri C, Vial F, Ryser-Degiorgis MP, Schwermer H, Darling K, Reist M, et al. Seroprevalence of Hepatitis E Virus in Domestic Pigs and Wild Boars in Switzerland. Zoonoses Public Health. 2014;61:537\u201344.","journal-title":"Zoonoses Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1146-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:56:15Z","timestamp":1718157375000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/15\/474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1146-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"article-number":"474"}}